Clinical Trials Logo
  1. Home
  2. Chorioretinitis
  3. NCT00372294

To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis

Chorioretinitis Clinical Trial

Clinical Trial Summary

Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin & Dexamethasone.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00372294
Study type Interventional
Source hahid Beheshti University of Medical Sciences
Contact
Status Active, not recruiting
Phase Phase 3
Start date July 2005
Completion date November 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT03753893 - Ocular Manifestations in Rheumatic Diseases
Recruiting NCT04245072 - Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis N/A
Recruiting NCT05335746 - Ocular Changes in Vitiligo Patients on Therapy
Withdrawn NCT01151462 - Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.